Key result
Ticagrelor and clopidogrel were evaluated for their comparative impact on postdischarge mild bleeding and clinical outcomes in patients with ST-elevation myocardial infarction.
Why the study?
Does ticagrelor compared to clopidogrel impact postdischarge mild bleeding in patients with ST-elevation myocardial infarction?
Does ticagrelor compared to clopidogrel impact postdischarge mild bleeding in patients with ST-elevation myocardial infarction?
Answers are grounded in this paper and cite their sources.
Ticagrelor was associated with more postdischarge mild bleeding and readmissions after STEMI; leaves open net clinical benefit versus clopidogrel in prospective trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Song et al. (2020) studied this question. Ticagrelor and clopidogrel were evaluated for their comparative impact on postdischarge mild bleeding and clinical outcomes in patients with ST-elevation myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: